YYYH yields 222222.22% · JNJ yields 2.13%● Live data
📍 YYYH pulled ahead of the other in Year 1
Combined, YYYH + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YYYH + JNJ for your $10,000?
China Yanyuan Yuhui Natl Ed Group Inc., a digital advertising technology company, develops and provides advertising software and service solutions in the United States. It operates an advertising technology platform, the MediaShift Monetization Platform, which deploys digital advertisements on WiFi networks at sign-in and while surfing the Internet through display ads and interstitial videos. Its target market comprises network providers offering Internet access to individual and business viewers; and Internet service providers, multiple system operators, and higher education venues with a fixed end-user base to airports, convention centers, hotels, coffee shops, and other venues. The company also operates EducationShift, which focuses on developments in journalism education and MetricShift, which provides content on metrics and analytics and measures impact through original reporting, aggregation, and audience engagement and community. The company sells its products and services directly, as well as through resellers. The company was formerly known as MediaShift, Inc. China Yanyuan Yuhui Natl Ed Group Inc. was founded in 2006 and is based in Oceanside, New York.
Full YYYH Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.